Search Results - xiaomin+song

2 Results Sort By:
Engineered Protein with Enhance Antibody Targeting and Cytotoxic Response Properties
Problem: Antibody-based therapies have demonstrated promising results. Following binding of the mAb to its tumor target, interactions of the Fc-portion with Fc-receptors (Fc-R) expressed by effector cells (e.g. natural killer (NK) cells, macrophages and T-cells) may result in complement-dependent cytotoxicity (CDC) and antibody-dependent cellular cytotoxicity...
Published: 7/16/2026   |   Updated: 7/16/2026   |   Inventor(s): Mark Greene, Hongtao Zhang, Xiaomin Song, Zhaocai Zhou, Ramachandran Murali, Masahide Tone, Zhiqiang Zhu, Lian Lam, Zheng Cai
Keywords(s): Bioengineering
Category(s): Technology Classifications > Therapeutics
2015-172 VERY-SMALL-NUCLEAR CIRCULATING TUMOR CELL (VSNCTC) AS A DIAGNOSTIC BIOMARKER OF VISCERAL METASTASIS IN ADVANCED PROSTATE CANCER
Very-Small-Nuclear Circulating Tumor Cell (vsnCTC) as a Diagnostic Biomarker of Visceral Metastasis in Advanced Prostate CancerTech ID: 30306 / UC Case 2015-172-2SUMMARYUCLA researchers in the Department of Molecular and Medical Pharmacology have identified a novel biomarker that can be used to diagnose prostate cancer patients for the presence of visceral...
Published: 7/20/2026   |   Updated: 9/6/2019   |   Inventor(s): Hsian-Rong Tseng, Jiaoti Huang, Zunfu Ke, Ker-Chau Li, Min Song, Edwin Posadas, Yi-Tsung Lu, Jake Lichterman, Leland Chung, Jiefu Chen
Keywords(s): Diagnostic Markers & Platforms, Diagnostic Platform Technologies (E.G. Microfluidics), Life Science Research Tools, Oncology
Category(s): Life Science Research Tools, Diagnostic Markers, Platforms > Diagnostic Platform Technologies, Therapeutics > Oncology